Dr. Trikalinos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 800-647-2098Fax+1 314-362-3192
Education & Training
- John Hopkins UniversityMaster's, Regulatory Science, 2016
- University of MarylandFellowship, Hematology and Medical Oncology, 2011 - 2014
- MetroWest Medical CenterResidency, Internal Medicine, 2007 - 2011
- University of Ioannina Faculty of MedicineClass of 2005
Certifications & Licensure
- IL State Medical License 2020 - 2026
- MO State Medical License 2017 - 2025
- MD State Medical License 2014 - 2017
- MA State Medical License 2010 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Excellence in Research Award US Oncology Network, 2015
- Outstanding Performance Award Metrowest Medical Center, 2011
- Compliance Award, Outstanding Documentation University of Maryland, 2011
- Join now to see all
Publications & Presentations
PubMed
- 269 citationsNeuroendocrine and adrenal tumors, version 2.2021Manisha H. Shah, Whitney S. Goldner, Al B. Benson, Emily K. Bergsland, Lawrence S. Blaszkowsky
Journal of the National Comprehensive Cancer Network. 2021-07-28 - 4 citationsPopulation-level changes in outcomes and Medicare cost following the introduction of new cancer therapies.Bora Youn, Ira B. Wilson, Vincent Mor, Nikolaos A. Trikalinos, Issa J Dahabreh
Health Services Research. 2021-03-07 - 53 citationsReal-world use and survival outcomes of immune checkpoint inhibitors in older adults with non-small cell lung cancer.Bora Youn, Nikolaos A. Trikalinos, Vincent Mor, Ira B. Wilson, Issa J Dahabreh
Cancer. 2020-03-01
Journal Articles
- FOLFIRINOX for the Treatment of Advanced Gastroesophageal CancersHaeseong Park, Andrea Wang-Gillam, Caron Rigden, Katrina S Pedersen, Nikolaos A Trikalinos, JAMA Oncology
- Socioeconomic status and survival in glioblastomaTrikalinos NA, Goloubeva O, Mehta MP, Kwok Y, Sausville E, Int J Clin Exp Med, 1/1/2016
- International ranking systems for universities and institutions: a critical appraisalIoannidis JP, et al, BMC Med, 1/25/2007
Abstracts/Posters
- Preoperative monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio are associated with overall survival after resection of pancreatic neuroendocrine tumors.Roheena Z. Panni, Bradley Krasnick, Jesse Davidson, Alexandra G. Lopez-Aguiar, Eleftherios Makris, George Poultsides, Zaheer Kanji, Flavio Rocha, Alexander V. Fisher, ..., Gastrointestinal Cancers Symposium, 1/1/2018
- A phase II trial of first-line FOLFIRINOX for patients with advanced gastroesophageal adenocarcinoma.Haeseong Park, Andrea Wang-Gillam, Rama Suresh, Caron E. Rigden, Manik A. Amin, Benjamin R. Tan Jr., Katrina Pedersen, Kian-Huat Lim, Nikolaos Trikalinos, Katherine Na..., Gastrointestinal Cancers Symposium, 1/1/2018
- Grade switch and survival in a cohort of 95 resected pancreatic neuroendocrine neoplasms (PanNEN).Nikolaos A Trikalinos, Chet Hammill, Gregory Williams, Jingxia Liu, William Hawkins and Deyali Chatterjee, North American Neuroendocrine Tumors Society Symposium, 1/1/2018
- Join now to see all
Authored Content
- FOLFIRINOX for the Treatment of Advanced Gastroesophageal CancersMay 2020
Press Mentions
- Siteman Cancer Center to Open North St. Louis County Location July 1June 30th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: